Nuvalent (NasdaqGS:NUVL) FY Conference Transcript

Nuvalent (NasdaqGS:NUVL) FY Conference March 04, 2026 09:45 AM ET Company ParticipantsAlex Balcom - CFOJames Porter - CEOConference Call ParticipantsMarc Frahm - Managing Director, Health Care – Biotechnology Research Analyst,Marc FrahmWelcome back to the 46th annual TD Cowen healthcare conference. I'm Marc Frahm from the TD Cowen Biotech team. We're really happy to have with us the, for the next session, the team here from Nuvalent. We've got Jim Porter, CEO, and Alex Balcom, CFO. Maybe to start off with, ...